Early research (Phase 1)Study completedNCT01143740What this trial is testingRO5045337 in Patients With Liposarcomas Prior to Debulking SurgeryWho this might be right forSarcoma Hoffmann-La Roche 20
Not applicableUnknownNCT00687778What this trial is testing11C-Acetate PET/CT Non-FDG-Avid TumorsWho this might be right forSoft Tissue SarcomasThyroid CancerLung Cancer+7 more Tel-Aviv Sourasky Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00860015What this trial is testingAlimta Plus Gemcitabine for Advanced SarcomaWho this might be right forSarcoma, Soft Tissue Columbia University 12
Not applicableLooking for participantsNCT07057765What this trial is testingPredictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCLWho this might be right forDLBCL - Diffuse Large B Cell LymphomaMarkers of Inflammation Ain Shams University 40
Large-scale testing (Phase 3)UnknownNCT02449343What this trial is testingStudy of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)Who this might be right forSoft Tissue Sarcoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 233
Testing effectiveness (Phase 2)UnknownNCT04606108What this trial is testingStudy of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue SarcomaWho this might be right forSoft Tissue Sarcoma Sun Yat-sen University 62
Testing effectiveness (Phase 2)Ended earlyNCT06630325What this trial is testingA Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic CancerWho this might be right forAdvanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+11 more OHSU Knight Cancer Institute 6
Not applicableStudy completedNCT05510908What this trial is testingUse of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMCWho this might be right forHIV-Associated Malignant NeoplasmHIV InfectionsCancer+5 more AIDS Malignancy Consortium 460
Very early researchActive Not RecruitingNCT04541108What this trial is testingPhase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer TherapiesWho this might be right forSolid Tumor Presage Biosciences 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652What this trial is testingEnsartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07650838What this trial is testingOVV-01 Injection Combined With AK112 Injection for the Treatment of Patients With Advanced Soft Tissue Sarcoma (STS)Who this might be right forSoft Tissue Sarcoma (STS) Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Not applicableUnknownNCT04990076What this trial is testingUltrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With HistologyWho this might be right forMyoma;UterusSarcoma Uterus Universitaire Ziekenhuizen KU Leuven 1,500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07820033What this trial is testingPsilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled TrialWho this might be right forAdvanced CancerStage IV Solid Tumor CancerStage IV Sarcoma of Bone+3 more University Health Network, Toronto 46
Not applicableEnded earlyNCT02900248What this trial is testingCureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceWho this might be right forNeoplasmsLung NeoplasmsColon Neoplasms+22 more CureOne 23
Testing effectiveness (Phase 2)Study completedNCT03220035What this trial is testingVemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+20 more National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT00118326What this trial is testingDonor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous DiseaseWho this might be right forKidney CancerLeukemiaLymphoma+3 more Fred Hutchinson Cancer Center
Not applicableStudy completedNCT01118078What this trial is testingBiomarkers in Tissue Samples From Patients With High-Risk Wilms TumorWho this might be right forClear Cell Sarcoma of the KidneyRecurrent Wilms Tumor and Other Childhood Kidney TumorsRhabdoid Tumor of the Kidney+5 more Children's Oncology Group 185
Testing effectiveness (Phase 2)UnknownNCT00204568What this trial is testingTrofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)Who this might be right forSarcoma, Soft Tissue University Hospital Schleswig-Holstein 117
Not applicableLooking for participantsNCT04749446What this trial is testingStudy on Clinical Features and Outcomes of Breast SarcomaWho this might be right forBreast Sarcoma Italian Sarcoma Group 300
Testing effectiveness (Phase 2)UnknownNCT04589754What this trial is testingAdriamycin and Ifosfamide Combined With SintilimabWho this might be right forSoft Tissue Sarcoma Sun Yat-sen University 176